Search results
These congressmen want to modify the Inflation Reduction Act to foster rare disease research
The Hill via Yahoo News· 2 hours agoReps. John Joyce (R-Pa.) and Wiley Nickel (D-N.C.) on Thursday discussed why they’re pushing to pass...
The privileged status of orphan medicines in Germany
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoIn Germany, new measures have come into effect as part of the GKV-FinStG Act in 2022 that put into question this market’s desirability for orphan drug...
CRISPR and other new technologies open doors for drug development, but which diseases get...
The Conversation via Yahoo News· 5 months agoDrug development takes a great deal of time, money and effort. While future profits play a big...
Column: Big drug makers are whining about having to negotiate with Medicare, but they can't afford...
LA Times via Yahoo Finance· 7 months agoMedicare is finally allowed to negotiate prescription drug prices with drug companies. But the...
Experts say FDA needs more regulatory flexibility
The Hill via Yahoo News· 1 year agoStrict regulations on drug safety and testing make it difficult to develop new treatments for rare, obscure and deadly diseases, according to experts. As...
AstraZeneca becomes first international company to file Medicare drug pricing suit
Yahoo Finance· 8 months agoAstraZeneca (AZN) has joined the legal fight against Medicare drug pricing negotiations, becoming...
Opinion: For drug access, Canadians with rare disorders are 40 years behind Americans
Financial Post via Yahoo Finance· 1 year agoBy Nigel Rawson and John Adams Forty years ago this month, the United States passed the Orphan Drug...
Can Axsome Hold Out Till Depression Drug Becomes a Blockbuster?
Motley Fool· 1 year agoAxsome Therapeutics' (NASDAQ: AXSM) psychiatric drug Auvelity could reach blockbuster status by the...
Opinion: On this rarest of days, commit to support those with rare diseases
Financial Post via Yahoo Finance· 2 months agoBy John Adams, Beth Vanstone and Nigel Rawson Feb. 29 — that rarest of days — is Rare Disease Day...
AstraZeneca sues US over Medicare drug price negotiation plans
Reuters via AOL· 8 months agoThe program faces at least seven other court challenges, including from leading industry group PhRMA...